Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Rigel Pharmaceuticals, Inc. - Common Stock (NQ:RIGL)

46.15 -1.64 (-3.43%)
Delayed Quote Updated: 3:24 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Rigel Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Rigel (RIGL) Q2 2026 Earnings Call Transcript ↗
VEPPANU launch and R289 data readouts drive second-half priorities. 
Via The Motley Fool
Topics Earnings
News headline image
Rigel Pharmaceuticals Q2 Earnings Call Highlights ↗
Rigel Pharmaceuticals (NASDAQ:RIGL) reported second-quarter 2026 total revenue of $78.7 million and net income of $17.3 million, while outlining plans to launch newly licensed breast cancer therapy... 
Via MarketBeat
Topics Earnings
News headline image
These Analysts Increase Their Forecasts On Arvinas After Q1 Results ↗
Arvinas Inc (NASDAQ:ARVN) reported Q1 losses of 90 cents/share, missed analyst estimates. Rigel Pharmaceuticals (NASDAQ:RIGL) announced global licensing agreement with Arvinas and Pfizer (NYSE:PFE) for... 
Via Benzinga
Rigel Pharmaceuticals (NASDAQ:RIGL) Q1 2026 Results Miss Revenue and EPS Estimates, Stock Declines After-Hours ↗
Via Chartmill
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL): A GARP Stock with Affordable Growth and Strong Fundamentals ↗
Via Chartmill
Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Shows Strong Growth and Technical Momentum ↗
Via Chartmill
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Presents a Compelling Case for Value Investors ↗
Via Chartmill
News headline image
Why One Fund’s $4 Million Centerra Gold Exit Looks Like Profit-Taking Amid a 150% Rally ↗
Centerra Gold operates integrated mining projects in North America and Turkey, generating revenue from gold, copper, and molybdenum sales. 
Via The Motley Fool
News headline image
This Fund Cashed Out of Preformed Line Products Amid a 150% Stock Surge ↗
Preformed Line Products designs and manufactures network hardware for utilities and telecoms across global infrastructure markets. 
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
News headline image
Stock Market Today, March 16: CytomX Therapeutics Surges After Positive Phase 1 Colorectal Cancer Data ↗
Today, March 16, 2026, investors weigh striking early colorectal cancer results against weak quarterly numbers and a finite cash runway. 
Via The Motley Fool
Topics Stocks
News headline image
Rigel Pharma (RIGL) Earnings Call Transcript ↗
Rigel Pharma (RIGL) Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) Emerges as a Top Affordable Growth Stock ↗
Rigel Pharmaceuticals (RIGL) presents a strong GARP investment case with high growth, solid profitability, and a notably low valuation compared to its biotech peers. 
Via Chartmill
News headline image
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) Presents a Strong 'Decent Value' Investment Case ↗
Rigel Pharmaceuticals (RIGL) presents a strong value investment case with a very low P/E ratio, robust financial health, and high earnings growth potential. 
Via Chartmill
News headline image
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) Meets Minervini Trend Template and High-Growth Momentum Criteria ↗
Rigel Pharmaceuticals (RIGL) aligns with Mark Minervini's growth strategy, showing a strong technical uptrend supported by accelerating earnings and revenue momentum. 
Via Chartmill
News headline image
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL): A GARP Investment with Strong Growth and a Reasonable Price ↗
Discover Rigel Pharmaceuticals (RIGL), a GARP stock with explosive growth, a low P/E ratio, and strong financials, offering value in the biotech sector. 
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Wednesday's session: gap up and gap down stocks ↗
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
These stocks that are showing activity before the opening bell on Wednesday. ↗
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Teradata Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
What's going on in today's after hours session ↗
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
A Look Ahead: Rigel Pharmaceuticals's Earnings Forecast ↗
 
Via Benzinga
News headline image
Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Shows Strong Alignment with Navellier's Growth Criteria ↗
Rigel Pharmaceuticals shows explosive growth, strong cash flow, and high ROE, aligning with Louis Navellier's proven stock-picking system for growth investors. 
Via Chartmill
News headline image
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) Combines Strong Growth and Bullish Technicals ↗
RIGL stock shows strong revenue & earnings growth with a low P/E ratio. Its technical chart pattern suggests a potential breakout from a recent trading range. 
Via Chartmill
News headline image
Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Embodies the 'Affordable Growth' Investment Strategy ↗
Rigel Pharmaceuticals offers strong growth and earnings at an affordable valuation, making it a compelling candidate for the "Affordable Growth" investment strategy. 
Via Chartmill
News headline image
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) Stands Out as a Top Growth Stock Candidate ↗
RIGL stock shows explosive growth with 5,567% EPS surge, soaring sales, and strong earnings surprises, fitting a proven growth investing model. 
Via Chartmill
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.